Opportunity and cost of sevelamer in dialysis patients
Authors:
- Ghazali AbderrhamaneGAGhazali Abderrhamane
- Demontis RenatoDRDemontis Renato
- Fievet PatrickFPFievet Patrick
- 1 April 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 67 (4) , 1636
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United StatesKidney International, 2004
- Survival of Patients Undergoing Hemodialysis with Paricalcitol or Calcitriol TherapyNew England Journal of Medicine, 2003
- Calcium kinetics and the long-term effects of lowering dialysate calcium concentrationKidney International, 1993
- Etiology of hyperparathyroidism and bone disease during chronic hemodialysisJournal of Clinical Investigation, 1971